# Fortune Brands Innovations, Inc.: financial statements, quarterly

FBIN · NYSE · CIK 1519751 · [Materials](/sectors/materials.md) · fiscal year ends Dec 27

Pages: [Overview](/companies/fbin.md) · [Financials](/companies/fbin/financials.md) · [Filings](/companies/fbin/filings.md) · [Insiders](/companies/fbin/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fbin/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,261](/filings/0000950170-24-122608.md) | [1,161 d](/filings/0001193125-26-063960.md) | [1,110](/filings/0000950170-25-065791.md) | [1,240](/filings/0000950170-25-100950.md) | [1,155](/filings/0001193125-25-258670.md) | [1,104 d](/filings/0001193125-26-063960.md) | [1,033](/filings/0001193125-26-211916.md) | [1,203](/filings/0001193125-26-335205.md) | [1,149](/filings/0001193125-25-258670.md) | [1,078 d](/filings/0001193125-26-063960.md) | [1,011](/filings/0001193125-26-211916.md) | [1,154](/filings/0001193125-26-335205.md) |
| Cost of revenue | $m | [721](/filings/0000950170-24-122608.md) | [666 d](/filings/0001193125-26-063960.md) | [622](/filings/0000950170-25-065791.md) | [699](/filings/0000950170-25-100950.md) | [626](/filings/0001193125-25-258670.md) | [596 d](/filings/0001193125-26-063960.md) | [578](/filings/0001193125-26-211916.md) | [660](/filings/0001193125-26-335205.md) | [630](/filings/0001193125-25-258670.md) | [605 d](/filings/0001193125-26-063960.md) | [576](/filings/0001193125-26-211916.md) | [563](/filings/0001193125-26-335205.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [321](/filings/0000950170-24-122608.md) | [306 d](/filings/0001193125-26-063960.md) | [312](/filings/0000950170-25-065791.md) | [320](/filings/0000950170-25-100950.md) | [298](/filings/0001193125-25-258670.md) | [310 d](/filings/0001193125-26-063960.md) | [315](/filings/0001193125-26-211916.md) | [339](/filings/0001193125-26-335205.md) | [313](/filings/0001193125-25-258670.md) | [325 d](/filings/0001193125-26-063960.md) | [353](/filings/0001193125-26-211916.md) | [344](/filings/0001193125-26-335205.md) |
| Operating income | $m | [197](/filings/0000950170-24-122608.md) | [134 d](/filings/0001193125-26-063960.md) | [155](/filings/0000950170-25-065791.md) | [199](/filings/0000950170-25-100950.md) | [205](/filings/0001193125-25-258670.md) | [178 d](/filings/0001193125-26-063960.md) | [97.0](/filings/0001193125-26-211916.md) | [172](/filings/0001193125-26-335205.md) | [126](/filings/0001193125-25-258670.md) | [122 d](/filings/0001193125-26-063960.md) | [60.2](/filings/0001193125-26-211916.md) | [(9.0)](/filings/0001193125-26-335205.md) |
| Interest expense | $m | [33.3](/filings/0000950170-24-122608.md) | [28.6 d](/filings/0001193125-26-063960.md) | [30.1](/filings/0000950170-25-065791.md) | [32.3](/filings/0000950170-25-100950.md) | [30.2](/filings/0001193125-25-258670.md) | [27.9 d](/filings/0001193125-26-063960.md) | [28.6](/filings/0001193125-26-211916.md) | [31.2](/filings/0001193125-26-335205.md) | [28.6](/filings/0001193125-25-258670.md) | [26.8 d](/filings/0001193125-26-063960.md) | [26.5](/filings/0001193125-26-211916.md) | [27.4](/filings/0001193125-26-335205.md) |
| Income tax | $m | [36.1](/filings/0000950170-24-122608.md) | [22.6 d](/filings/0001193125-26-063960.md) | [28.8](/filings/0000950170-25-065791.md) | [36.6](/filings/0000950170-25-100950.md) | [39.9](/filings/0001193125-25-258670.md) | [28.2 d](/filings/0001193125-26-063960.md) | [18.0](/filings/0001193125-26-211916.md) | [47.4](/filings/0001193125-26-335205.md) | [23.9](/filings/0001193125-25-258670.md) | [16.8 d](/filings/0001193125-26-063960.md) | [9.6](/filings/0001193125-26-211916.md) | [(14.5)](/filings/0001193125-26-335205.md) |
| Net income | $m | [137](/filings/0000950170-24-122608.md) | [81.3 d](/filings/0001193125-26-063960.md) | [96.4](/filings/0000950170-25-065791.md) | [134](/filings/0000950170-25-100950.md) | [137](/filings/0001193125-25-258670.md) | [105 d](/filings/0001193125-26-063960.md) | [51.4](/filings/0001193125-26-211916.md) | [100](/filings/0001193125-26-335205.md) | [70.8](/filings/0001193125-25-258670.md) | [76.4 d](/filings/0001193125-26-063960.md) | [24.2](/filings/0001193125-26-211916.md) | [(22.5)](/filings/0001193125-26-335205.md) |
| Diluted EPS | $ per share | [1.07](/filings/0000950170-24-122608.md) | not reported | [0.76](/filings/0000950170-25-065791.md) | [1.06](/filings/0000950170-25-100950.md) | [1.09](/filings/0001193125-25-258670.md) | not reported | [0.42](/filings/0001193125-26-211916.md) | [0.83](/filings/0001193125-26-335205.md) | [0.59](/filings/0001193125-25-258670.md) | not reported | [0.20](/filings/0001193125-26-211916.md) | [(0.19)](/filings/0001193125-26-335205.md) |
| Basic EPS | $ per share | [1.08](/filings/0000950170-24-122608.md) | not reported | [0.77](/filings/0000950170-25-065791.md) | [1.07](/filings/0000950170-25-100950.md) | [1.10](/filings/0001193125-25-258670.md) | not reported | [0.42](/filings/0001193125-26-211916.md) | [0.83](/filings/0001193125-26-335205.md) | [0.59](/filings/0001193125-25-258670.md) | not reported | [0.20](/filings/0001193125-26-211916.md) | [(0.19)](/filings/0001193125-26-335205.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [453](/filings/0000950170-23-056045.md) | [366](/filings/0000950170-25-026763.md) | [360](/filings/0000950170-24-051261.md) | [353](/filings/0000950170-24-086908.md) | [345](/filings/0000950170-24-122608.md) | [381](/filings/0001193125-26-063960.md) | [340](/filings/0000950170-25-065791.md) | [235](/filings/0000950170-25-100950.md) | [224](/filings/0001193125-25-258670.md) | [264](/filings/0001193125-26-335205.md) | [223](/filings/0001193125-26-211916.md) | [210](/filings/0001193125-26-335205.md) |
| Current assets | $m | [2,150](/filings/0000950170-23-056045.md) | [2,046](/filings/0000950170-25-026763.md) | [2,172](/filings/0000950170-24-051261.md) | [2,082](/filings/0000950170-24-086908.md) | [2,019](/filings/0000950170-24-122608.md) | [2,007](/filings/0001193125-26-063960.md) | [2,062](/filings/0000950170-25-065791.md) | [2,007](/filings/0000950170-25-100950.md) | [2,010](/filings/0001193125-25-258670.md) | [1,974](/filings/0001193125-26-335205.md) | [2,024](/filings/0001193125-26-211916.md) | [2,075](/filings/0001193125-26-335205.md) |
| Total assets | $m | [6,618](/filings/0000950170-23-056045.md) | [6,565](/filings/0001193125-26-063960.md) | [6,792](/filings/0000950170-24-051261.md) | [6,674](/filings/0000950170-24-086908.md) | [6,598](/filings/0000950170-24-122608.md) | [6,562](/filings/0001193125-26-063960.md) | [6,585](/filings/0000950170-25-065791.md) | [6,596](/filings/0000950170-25-100950.md) | [6,519](/filings/0001193125-25-258670.md) | [6,521](/filings/0001193125-26-335205.md) | [6,546](/filings/0001193125-26-211916.md) | [6,342](/filings/0001193125-26-335205.md) |
| Current liabilities | $m | [1,192](/filings/0000950170-23-056045.md) | [1,200](/filings/0000950170-25-026763.md) | [1,063](/filings/0000950170-24-051261.md) | [1,548](/filings/0000950170-24-086908.md) | [1,532](/filings/0000950170-24-122608.md) | [1,602](/filings/0001193125-26-063960.md) | [1,462](/filings/0000950170-25-065791.md) | [1,016](/filings/0000950170-25-100950.md) | [1,031](/filings/0001193125-25-258670.md) | [1,072](/filings/0001193125-26-335205.md) | [949](/filings/0001193125-26-211916.md) | [1,031](/filings/0001193125-26-335205.md) |
| Total liabilities | $m | [4,399](/filings/0000950170-23-056045.md) | [4,272](/filings/0000950170-25-026763.md) | [4,511](/filings/0000950170-24-051261.md) | [4,343](/filings/0000950170-24-086908.md) | [4,203](/filings/0000950170-24-122608.md) | [4,140](/filings/0001193125-26-063960.md) | [4,280](/filings/0000950170-25-065791.md) | [4,256](/filings/0000950170-25-100950.md) | [4,140](/filings/0001193125-25-258670.md) | [4,132](/filings/0001193125-26-335205.md) | [4,189](/filings/0001193125-26-211916.md) | [4,034](/filings/0001193125-26-335205.md) |
| Long-term debt | $m | [2,829](/filings/0000950170-23-056045.md) | [2,670](/filings/0000950170-25-026763.md) | [3,045](/filings/0000950170-24-051261.md) | [2,402](/filings/0000950170-24-086908.md) | [2,278](/filings/0000950170-24-122608.md) | [2,174](/filings/0001193125-26-063960.md) | [2,454](/filings/0000950170-25-065791.md) | [2,812](/filings/0000950170-25-100950.md) | [2,655](/filings/0001193125-25-258670.md) | [2,545](/filings/0001193125-26-335205.md) | [2,714](/filings/0001193125-26-211916.md) | [2,552](/filings/0001193125-26-335205.md) |
| Current portion of debt | $m | not reported | [0.0](/filings/0000950170-25-026763.md) | not reported | not reported | not reported | [500](/filings/0001193125-26-063960.md) | [500](/filings/0000950170-25-065791.md) | [0.0](/filings/0000950170-25-100950.md) | [0.0](/filings/0001193125-25-258670.md) | [0.0](/filings/0001193125-26-063960.md) | not reported | not reported |
| Short-term borrowings | $m | [0.0](/filings/0000950170-23-056045.md) | [0.0](/filings/0000950170-25-026763.md) | not reported | [499](/filings/0000950170-24-086908.md) | [500](/filings/0000950170-24-122608.md) | [500](/filings/0001193125-26-063960.md) | [500](/filings/0000950170-25-065791.md) | [0.0](/filings/0000950170-25-100950.md) | [0.0](/filings/0001193125-25-258670.md) | [0.0](/filings/0001193125-26-063960.md) | not reported | not reported |
| Shareholders' equity | $m | [2,219](/filings/0000950170-24-122608.md) | [2,293](/filings/0001193125-26-063960.md) | [2,281](/filings/0000950170-25-100950.md) | [2,331](/filings/0001193125-25-258670.md) | [2,396](/filings/0001193125-25-258670.md) | [2,422](/filings/0001193125-26-335205.md) | [2,305](/filings/0001193125-26-335205.md) | [2,340](/filings/0001193125-26-335205.md) | [2,379](/filings/0001193125-25-258670.md) | [2,389](/filings/0001193125-26-335205.md) | [2,357](/filings/0001193125-26-335205.md) | [2,308](/filings/0001193125-26-335205.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [332 d](/filings/0000950170-24-122608.md) | [220 d](/filings/0001193125-26-063960.md) | [(71.3)](/filings/0000950170-25-065791.md) | [262 d](/filings/0000950170-25-100950.md) | [205 d](/filings/0001193125-25-258670.md) | [272 d](/filings/0001193125-26-063960.md) | [(83.4)](/filings/0001193125-26-211916.md) | [149 d](/filings/0001193125-26-335205.md) | [204 d](/filings/0001193125-25-258670.md) | [208 d](/filings/0001193125-26-063960.md) | [(119)](/filings/0001193125-26-211916.md) | [203 d](/filings/0001193125-26-335205.md) |
| Capital expenditure | $m | [63.5 d](/filings/0000950170-24-122608.md) | [80.8 d](/filings/0001193125-26-063960.md) | [64.6](/filings/0000950170-25-065791.md) | [38.8 d](/filings/0000950170-25-100950.md) | [29.7 d](/filings/0001193125-25-258670.md) | [60.2 d](/filings/0001193125-26-063960.md) | [29.2](/filings/0001193125-26-211916.md) | [30.7 d](/filings/0001193125-26-335205.md) | [27.4 d](/filings/0001193125-25-258670.md) | [24.5 d](/filings/0001193125-26-063960.md) | [20.3](/filings/0001193125-26-211916.md) | [23.5 d](/filings/0001193125-26-335205.md) |
| Dividends paid | $m | [29.2 d](/filings/0000950170-24-122608.md) | [29.0 d](/filings/0001193125-26-063960.md) | [30.1](/filings/0000950170-25-065791.md) | [30.1 d](/filings/0000950170-25-100950.md) | [29.8 d](/filings/0001193125-25-258670.md) | [29.6 d](/filings/0001193125-26-063960.md) | [30.5](/filings/0001193125-26-211916.md) | [30.1 d](/filings/0001193125-26-335205.md) | [30.0 d](/filings/0001193125-25-258670.md) | [30.0 d](/filings/0001193125-26-063960.md) | [31.2](/filings/0001193125-26-211916.md) | [31.0 d](/filings/0001193125-26-335205.md) |
| Share repurchases | $m | [20.1 d](/filings/0000950170-24-122608.md) | [29.9 d](/filings/0001193125-26-063960.md) | [100](/filings/0000950170-25-065791.md) | [50.2 d](/filings/0000950170-25-100950.md) | [40.2 d](/filings/0001193125-25-258670.md) | [50.0 d](/filings/0001193125-26-063960.md) | [175](/filings/0001193125-26-211916.md) | [62.8 d](/filings/0001193125-26-335205.md) | [0.0 d](/filings/0001193125-25-258670.md) | [10.0 d](/filings/0001193125-26-063960.md) | [43.5](/filings/0001193125-26-211916.md) | [1.7 d](/filings/0001193125-26-335205.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [129](/filings/0000950170-23-005127.md) | [129](/filings/0000950170-24-051261.md) | [128](/filings/0000950170-24-086908.md) | [128](/filings/0000950170-24-122608.md) | [127](/filings/0000950170-25-065791.md) | [126](/filings/0000950170-25-100950.md) | [125](/filings/0001193125-25-258670.md) | [123](/filings/0001193125-26-211916.md) | [121](/filings/0001193125-26-335205.md) | [121](/filings/0001193125-25-258670.md) | [120](/filings/0001193125-26-211916.md) | [119](/filings/0001193125-26-335205.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 119,371,477 at 2026-07-17, from the cover of the [10-Q filed 2026-08-05](/filings/0001193125-26-335205.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.